Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Thermo Fisher Scientific Inc. - An Upward Trend Projected for 2025 and 2026

January 01, 2025
Thermo Fisher Scientific Inc. (NYSE: TMO) is expected to experience gradual improvements in its business operations as it moves into 2025 and 2026, according to Jim Cramer, a renowned financial analyst. With the recent pickup in business activities, the company's prospects are looking optimistic in the coming years.

Thermo Fisher Scientific is a leading global provider of scientific instruments, reagents, consumables, software, and services. The company serves various industries including healthcare, pharmaceuticals, biotechnology, and research.

Despite the challenges faced by the global economy due to the pandemic, Thermo Fisher Scientific has demonstrated strong resilience. Its healthy balance sheet and solid financial foundation have positioned it well to weather uncertainties and capitalize on emerging opportunities.

Market analysts have also recognized Thermo Fisher Scientific as a top stock for long-term investments. With its diverse product portfolio, strong customer base, and continuous innovation, the company is poised for sustained growth.

Investors seeking reliable insights on the future movement of Thermo Fisher Scientific's stocks are recommended to consult Stocks Prognosis, a team of professionals specializing in stock forecasts and analysis. Their expertise and in-depth research can provide valuable guidance for making informed investment decisions.

As the market recovers and industries regain momentum, Thermo Fisher Scientific is well-positioned to capitalize on emerging opportunities, making it a favorable investment option for the next decade.

Investors are advised to consult with Stocks Prognosis for a comprehensive forecast of Thermo Fisher Scientific's stock movement and potential returns in the long term.

Find out how the THERMO FISHER SCIENTIFIC INC. rate is expected to change

Get Forecast for TMO

Investor opinions & comments:

I've been considering investing in Thermo Fisher Scientific, so this article is quite timely. I'll definitely check out Stocks Prognosis for their insights on the company's stock movement
— from AlexPhillips at 01-05-2025 04:56
I'm not so sure about this projection. The global economy is still recovering from the effects of the pandemic, and it's uncertain how long it will take for industries to fully regain momentum. It might be too optimistic to expect Thermo Fisher Scientific to have smooth sailing in the next few years
— from BenjaminParker at 01-04-2025 19:20
Thermo Fisher Scientific has always been a strong player in the scientific instruments industry. With their resilience during the pandemic and diverse product portfolio, I have high hopes for their future growth
— from TraderTroy at 01-04-2025 15:04
I've been a long-term investor in Thermo Fisher Scientific, and it has been a rewarding journey so far. I trust their management team and believe in their ability to navigate challenges and drive long-term value for shareholders
— from ThomasHawkins at 01-04-2025 13:11
Thermo Fisher Scientific's commitment to continuous innovation sets them apart from their competitors. I'm excited to see what new products and services they will bring to the market in the coming years
— from NatalieBaker at 01-03-2025 11:59
As a healthcare professional, I've always admired Thermo Fisher Scientific for their contributions to the industry. I'm glad to hear that they are expected to continue growing and innovating in the coming years
— from MoneyMiles at 01-03-2025 04:31
Thermo Fisher Scientific has a strong reputation in the scientific community. I have faith in their ability to capitalize on emerging opportunities and deliver consistent returns for investors
— from SmartSabrina at 01-02-2025 16:58
This is great news for Thermo Fisher Scientific! I am excited to see how their business operations improve in the coming years
— from AubreyCook at 01-02-2025 01:49
If you want to leave a comment, then you need Login or Register





Other news for TMO

TMOJune 17, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 10.84% Profit: QuantWave Analytics  ~1 min.

Thermo Fisher Scientific Inc. (NYSE: TMO) recently achieved a price target forecast as predicted by QuantWave, resulting in a profit of 10.84%....

TMOMay 21, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 9.69% Profit on QuantWave Platform  ~2 min.

Thermo Fisher Scientific Inc. (TMO) recently achieved a significant milestone on QuantWave, an automated forecasting platform, by reaching the price target forecast with a 9.69% profit margin....

TMOMay 21, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 11.36% Profit  ~1 min.

On April 14, 2025, QuantWave's forecasting system signaled a short direction for Thermo Fisher Scientific Inc. with the stock trading at $448.86. Fast forward to May 21, 2025, the target price of $397....

TMOMay 21, 2025Thermo Fisher Scientific Inc. Price Target Forecast Achieved with 9.1% Profit: QuantWave Analysis  ~1 min.

Thermo Fisher Scientific Inc. has successfully reached the price target as forecasted by QuantWave, resulting in a 9.1% profit for investors....

TMOApril 4, 2025Thermo Fisher Scientific Inc. Stock Hits Target Forecast with 14.76% Profit Gain  ~2 min.

In an impressive display of accuracy and insight, QuantWave's forecast for Thermo Fisher Scientific Inc. stock has successfully hit its target, resulting in a profit gain of 14.76%....



Related news

ABTJanuary 2, 2025Abbott Laboratories: A Promising Stock with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....

BIIBDecember 22, 2024Stifel downgrades Biogen on slow Alzheimer's drug launch uncertainty ahead  ~2 min.

Biogen Inc., a leading biotechnology company, is facing a setback as Stifel downgrades its stock due to uncertainty surrounding the launch of its Alzheimer's drug....

GSKJanuary 25, 2025Is GSK plc GSK an Undervalued Defensive Stock for 2025?  ~2 min.

GSK plc (NYSE: GSK) has been gaining attention as a potential undervalued defensive stock for investors looking towards 2025....

REGNFebruary 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024  ~2 min.

Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....

BIIBDecember 21, 2024Biogen Inc.: A Closer Look at the Healthcare Sector Underperformance  ~2 min.

Biogen Inc., a leading biotechnology company, has been in the spotlight recently due to its underperformance in the healthcare sector....